Nektar Therapeutics
NKTR
#5687
Rank
A$1.74 B
Marketcap
A$85.66
Share price
-1.37%
Change (1 day)
261.12%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are A$62.6 Million. In 2024 the company made an earning of -A$0.18 Billion, an increase over its 2023 earnings that were of -A$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-1.98%
2024 -A$0.18 Billion-56.85%
2023 -A$0.42 Billion-24.31%
2022 -A$0.55 Billion-30.25%
2021 -A$0.79 Billion17.87%
2020 -A$0.67 Billion0.88%
2019 -A$0.67 Billion-164.46%
2018 A$1.02 B-810.61%
2017 -A$0.15 Billion-37.06%
2016 -A$0.23 Billion89.22%
2015 -A$0.13 Billion48.22%
2014 -A$81.95 Million-65.93%
2013 -A$0.25 Billion-6.81%
2012 -A$0.26 Billion28.95%
2011 -A$0.21 Billion258.8%
2010 -A$55.79 Million-63.94%
2009 -A$0.16 Billion-392.45%
2008 A$52.9 M-211.74%
2007 -A$47.35 Million-79.57%
2006 -A$0.24 Billion-16.9%
2005 -A$0.28 Billion81.53%
2004 -A$0.16 Billion54.19%
2003 -A$99.65 Million-33.87%
2002 -A$0.16 Billion-9.6%
2001 -A$0.17 Billion73.39%
2000 -A$96.13 Million108.9%
1999 -A$46.02 Million39.48%
1998 -A$33 Million60.02%
1997 -A$20.62 Million18.05%
1996 -A$17.47 Million31.82%
1995 -A$13.25 Million57.14%
1994 -A$8.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.41 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.76 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
A$0.22 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.70 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-A$0.41 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.61 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
A$48.77 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA